1. Home
  2. TCBK vs BRVE Comparison

TCBK vs BRVE Comparison

Compare TCBK & BRVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TriCo Bancshares

TCBK

TriCo Bancshares

N/A

Current Price

$48.38

Market Cap

1.7B

Sector

Finance

ML Signal

N/A

Logo Braveheart Bio Inc. Common Stock

BRVE

Braveheart Bio Inc. Common Stock

N/A

Current Price

$20.45

Market Cap

1.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TCBK
BRVE
Founded
1975
2024
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.8B
IPO Year
1995
2026

Fundamental Metrics

Financial Performance
Metric
TCBK
BRVE
Price
$48.38
$20.45
Analyst Decision
Hold
Strong Buy
Analyst Count
6
5
Target Price
★ $57.84
$45.50
AVG Volume (30 Days)
226.5K
★ 473.2K
Earning Date
10-22-2026
11-10-2026
Dividend Yield
★ 2.92%
N/A
EPS Growth
★ 6.94
N/A
EPS
★ 3.29
N/A
Revenue
★ $53,445,000.00
N/A
Revenue This Year
$7.81
N/A
Revenue Next Year
$4.16
N/A
P/E Ratio
$15.01
★ N/A
Revenue Growth
★ 4.12
N/A
52 Week Low
$45.37
$16.70
52 Week High
$61.71
$32.00

Technical Indicators

Market Signals
Indicator
TCBK
BRVE
Relative Strength Index (RSI) 30.35 49.49
Support Level $45.65 $17.52
Resistance Level $51.37 $22.04
Average True Range (ATR) 1.13 1.76
MACD -0.40 0.07
Stochastic Oscillator 0.00 67.28

Price Performance

Historical Comparison
TCBK
BRVE

About TCBK TriCo Bancshares

TriCo Bancshares is a California corporation organized to act as a bank holding company for Tri Counties Bank. The Bank is a California-chartered bank that is engaged in the general commercial and retail banking business in California counties. The Bank provides a breadth of personal, small business, and commercial financial services, including accepting demand, savings and time deposits and making small business, commercial, real estate, and consumer loans, as well as a range of treasury management services and other customary banking services including safe deposit boxes at some branches. The company's primary source of revenue is the net interest income. Its banking and financial services are provided through full-service branches and commercial banking offices across California.

About BRVE Braveheart Bio Inc. Common Stock

Braveheart Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and other cardiovascular diseases. Its flagship product candidate, BHB-1893, is an oral small-molecule cardiac myosin inhibitor being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM).

Share on Social Networks: